Shoko Goto
Overview
Explore the profile of Shoko Goto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakurai Y, Iwasaki F, Hirose A, Matsumoto N, Miyagawa N, Keino D, et al.
J Pediatr Hematol Oncol
. 2024 May;
46(5):233-240.
PMID: 38691057
Metronomic chemotherapy (MC) is based on chronic administration of chemotherapeutic agents at minimally toxic doses without prolonged drug-free breaks, that inhibits tumor angiogenesis and induces tumor dormancy. This study aimed...
2.
Kutsukake M, Kuwabara N, Miyate Y, Kudo K, Goto S, Taira E, et al.
Endocr J
. 2023 Oct;
70(12):1123-1130.
PMID: 37793884
In adrenal fasciculata cells stimulated by ACTH, Ca and cAMP play indispensable roles as second messengers in cortisol production. However, whether their second messengers cooperatively or independently participate in steroid...
3.
Yokosuka T, Ito M, Yoshino Y, Hirose A, Nakamura W, Sakurai Y, et al.
Br J Haematol
. 2021 Nov;
196(3):764-768.
PMID: 34816427
Approximately 20% of patients with transient abnormal myelopoiesis (TAM) die due to hepatic or multiorgan failure. To identify potential new treatments for TAM, we performed in vitro drug sensitivity testing...
4.
Goto H, Yoshino Y, Ito M, Nagai J, Kumamoto T, Inukai T, et al.
Cancer Chemother Pharmacol
. 2021 Jul;
88(6):1055-1056.
PMID: 34275013
No abstract available.
5.
Keino D, Yokosuka T, Hirose A, Sakurai Y, Nakamura W, Fujita S, et al.
Pediatr Blood Cancer
. 2020 Aug;
67(11):e28655.
PMID: 32798298
Background: Preclinical observations suggested a synergistic effect of sorafenib (SFN) and irinotecan (CPT-11) in hepatoblastoma (HB). Thus, we conducted a feasibility study of fractionated CPT-11 combined with SFN to develop...
6.
Goto H, Yoshino Y, Ito M, Nagai J, Kumamoto T, Inukai T, et al.
Cancer Chemother Pharmacol
. 2020 Mar;
85(4):773-783.
PMID: 32144432
Purpose: Acute lymphoblastic leukemia (ALL) is curable with standardized chemotherapy. However, the development of novel therapies is still required, especially for patients with relapsed or refractory disease. By utilizing an...
7.
Nakamura W, Goto H, Hayashi A, Keino D, Sugiyama M, Miyagawa N, et al.
Pediatr Int
. 2020 Mar;
62(8):907-910.
PMID: 32124502
Background: Abnormal blood cell counts are characteristic of patients with Down syndrome and transient abnormal myelopoiesis (TAM). Although some patients with TAM experience prolonged anemia or thrombocytopenia, hematological factors predicting...
8.
Tsurusaki Y, Nagai J, Fujita S, Sugiyama M, Nakamura W, Hayashi A, et al.
Pediatr Blood Cancer
. 2019 Sep;
67(1):e28019.
PMID: 31556219
No abstract available.
9.
Nagahora N, Goto S, Inatomi T, Tokumaru H, Matsubara K, Shioji K, et al.
J Org Chem
. 2018 May;
83(12):6373-6381.
PMID: 29792430
The Buchwald-Hartwig amination of a phosphinine bearing a bromophenyl moiety was carried out using a dinuclear Ni catalyst. A variety of monoarylamines, diarylamines, and alkylamine, as well as heterocycles, were...
10.
Nagahora N, Yahata S, Goto S, Shioji K, Okuma K
J Org Chem
. 2018 Feb;
83(4):1969-1975.
PMID: 29392944
The transformation of 1,2-bis(1-arylvinyl)ditellurides into 2,5-diaryltellurophenes by sequential ditelluride exchange and thermal intramolecular cyclization reactions is presented, and the optoelectronic properties of a series of 2,5-diaryltellurophenes with both electron-donating and...